The Cigna Group (NYSE:CI) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. reduced its stake in shares of The Cigna Group (NYSE:CI - Free Report) by 1.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 495,403 shares of the health services provider's stock after selling 9,603 shares during the period. Victory Capital Management Inc. owned 0.18% of The Cigna Group worth $171,627,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Aptus Capital Advisors LLC grew its holdings in shares of The Cigna Group by 2.5% during the third quarter. Aptus Capital Advisors LLC now owns 2,613 shares of the health services provider's stock valued at $905,000 after buying an additional 64 shares in the last quarter. Aigen Investment Management LP increased its stake in shares of The Cigna Group by 147.1% in the 3rd quarter. Aigen Investment Management LP now owns 1,883 shares of the health services provider's stock valued at $652,000 after purchasing an additional 1,121 shares during the last quarter. Prime Capital Investment Advisors LLC boosted its position in shares of The Cigna Group by 7.5% during the third quarter. Prime Capital Investment Advisors LLC now owns 3,125 shares of the health services provider's stock valued at $1,082,000 after buying an additional 218 shares during the last quarter. Savvy Advisors Inc. bought a new stake in shares of The Cigna Group in the third quarter valued at $336,000. Finally, Sumitomo Mitsui Trust Group Inc. grew its stake in The Cigna Group by 1.8% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 784,034 shares of the health services provider's stock valued at $271,621,000 after buying an additional 13,814 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company's stock.

Insider Activity at The Cigna Group

In other news, Director William J. Delaney III sold 2,691 shares of the business's stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the completion of the sale, the director now owns 17,539 shares in the company, valued at approximately $6,010,264.52. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CI has been the topic of several analyst reports. Barclays lifted their price target on shares of The Cigna Group from $405.00 to $420.00 and gave the stock an "overweight" rating in a report on Tuesday, November 5th. Royal Bank of Canada dropped their price objective on The Cigna Group from $384.00 to $377.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. StockNews.com downgraded shares of The Cigna Group from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a "buy" rating for the company in a research note on Monday, November 4th. Finally, JPMorgan Chase & Co. increased their price objective on The Cigna Group from $435.00 to $438.00 and gave the company an "overweight" rating in a research report on Wednesday, August 21st. One equities research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $394.64.

The Cigna Group Stock Performance

Shares of NYSE:CI traded down $7.98 on Wednesday, reaching $331.89. 661,098 shares of the company's stock were exchanged, compared to its average volume of 1,539,169. The company has a market capitalization of $92.32 billion, a price-to-earnings ratio of 31.34, a PEG ratio of 1.02 and a beta of 0.51. The Cigna Group has a twelve month low of $253.95 and a twelve month high of $370.83. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The company has a fifty day moving average of $340.84 and a 200-day moving average of $340.08.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company had revenue of $63.70 billion during the quarter, compared to analysts' expectations of $59.58 billion. During the same quarter in the prior year, the company earned $6.77 EPS. The firm's revenue was up 29.8% on a year-over-year basis. On average, research analysts predict that The Cigna Group will post 28.5 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be paid a dividend of $1.40 per share. The ex-dividend date is Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.69%. The Cigna Group's dividend payout ratio (DPR) is presently 52.83%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.